Position in NVS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,351,866
+$503,493 QoQ
Shares Held
8,626
+55.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#537
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $139,775,642 across 13 Drug Manufacturers - General names. NVS ranks #11 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,940 | $35,910,936 | |
| 2 | JNJ |
Johnson & Johnson
|
112,529 | $28,578,989 | |
| 3 | MRK |
Merck & Co., Inc.
|
194,020 | $24,931,570 | |
| 4 | ABBV |
AbbVie Inc.
|
68,165 | $17,153,039 | |
| 5 | AMGN |
Amgen Inc
|
33,837 | $12,253,054 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
55,634 | $7,028,799 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
90,768 | $5,230,051 | |
| 8 | PFE |
Pfizer Inc
|
150,996 | $3,635,983 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,351,866 | 8,626 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $848,373 | 5,554 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $779,654 | 5,655 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $728,787 | 5,683 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $630,946 | 5,214 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $607,677 | 5,451 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $498,032 | 5,118 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $586,486 | 5,099 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $518,459 | 4,870 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $489,066 | 5,056 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $500,507 | 4,957 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $521,522 | 5,120 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $464,487 | 4,603 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $630,200 | 6,850 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $499,144 | 5,530 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $248,856 | 3,274 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $827,717 | 9,792 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $842,751 | 9,604 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $904,789 | 10,344 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $771,757 | 9,437 | Shares | Sole | 2022-01-13 | |
| 2021-06-30 | $874,900 | 9,589 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $834,626 | 9,764 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $833,533 | 8,827 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $768,900 | 8,842 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $771,037 | 8,828 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $725,642 | 8,801 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||